Immuneering Corp. (IMRX)
4.61
-0.17
(-3.56%)
USD |
NASDAQ |
Sep 09, 14:40
Immuneering Price to Book Value : 1.564 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.621 |
| September 04, 2026 | 1.635 |
| September 03, 2026 | 1.710 |
| September 02, 2026 | 1.703 |
| September 01, 2026 | 1.645 |
| August 31, 2026 | 1.693 |
| August 28, 2026 | 1.693 |
| August 27, 2026 | 1.767 |
| August 26, 2026 | 1.747 |
| August 25, 2026 | 1.774 |
| August 24, 2026 | 1.757 |
| August 21, 2026 | 1.798 |
| August 20, 2026 | 1.781 |
| August 19, 2026 | 1.808 |
| August 18, 2026 | 1.706 |
| August 17, 2026 | 1.771 |
| August 14, 2026 | 1.716 |
| August 13, 2026 | 1.764 |
| August 12, 2026 | 1.720 |
| August 11, 2026 | 1.628 |
| August 10, 2026 | 1.537 |
| August 07, 2026 | 1.530 |
| August 06, 2026 | 1.513 |
| August 05, 2026 | 1.489 |
| August 04, 2026 | 1.492 |
| Date | Value |
|---|---|
| August 03, 2026 | 1.414 |
| July 31, 2026 | 1.401 |
| July 30, 2026 | 1.435 |
| July 29, 2026 | 1.376 |
| July 28, 2026 | 1.438 |
| July 27, 2026 | 1.479 |
| July 24, 2026 | 1.465 |
| July 23, 2026 | 1.489 |
| July 22, 2026 | 1.516 |
| July 21, 2026 | 1.513 |
| July 20, 2026 | 1.455 |
| July 17, 2026 | 1.574 |
| July 16, 2026 | 1.621 |
| July 15, 2026 | 1.750 |
| July 14, 2026 | 1.767 |
| July 13, 2026 | 1.750 |
| July 10, 2026 | 1.733 |
| July 09, 2026 | 1.818 |
| July 08, 2026 | 1.876 |
| July 07, 2026 | 1.730 |
| July 06, 2026 | 1.744 |
| July 02, 2026 | 1.760 |
| July 01, 2026 | 1.713 |
| June 30, 2026 | 1.693 |
| June 29, 2026 | 1.582 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.620 |
| ACADIA Pharmaceuticals, Inc. | 3.672 |
| Alnylam Pharmaceuticals, Inc. | 25.11 |
| Anika Therapeutics, Inc. | 2.050 |
| Savara, Inc. | 7.728 |
Price to Book Value Related Metrics
| Price | 4.61 |
| Earnings Yield | -22.38% |
| Market Cap | 298.26M |